Saluda Medical

Our European Smart Faculty Group met in Amsterdam last week to discuss biomarker-based dosing in SCS, and to learn about our next-generation product launch which will take place in the coming months across Europe. Thank you to our faculty for your support and collaboration, and a special thank you to Dr. Johnathan Goree for joining us from the US to share his real-world experience of using neural dosing in his practice. Harold Nijhuis Jan Willem Kallewaard @Frank Huygen Johan Van de Minkelis Serge Nikolic Simon Thomson Prof. Dr. Jarek Maciaczyk Tony Van Havenbergh Karel Hanssens Johnathan Goree Clair Jackson Tim Palmer Jeff Colella Dave Mugan Sander van Geel Dr. Catharina Zielinski Peter Shepherd Rene Kraaiveld Celine Neutens Katharina Hermanski

Authors concluded “…it is imperative that we as a field reshape how we evaluate SCS. Similar to recently published RCTs in the space, expectations for pain relief should include objective improvements in quality of life measures.” To read the Tim Deer, MD et. al., Letter to the Editor in Pain Medicine, visit: https://lnkd.in/gdq435tp #KnowtheDose #ControltheDose #BiomarkerbasedDosing #Closedloop To read about the science and evidence behind SmartLoop® technology including holistic response beyond pain scores, visit: https://lnkd.in/eDFCwzfw

Join the October International Neuromodulation Society Journal Club Webinar this Thursday, October 17th to learn more about the use of biomarkers for optimization of spinal cord stimulation. Register here for free: https://lnkd.in/eHVNrAH

Join us at the American Society of Pain and Neuroscience ASPN Collaborative Pain Summit this weekend in Nashville, TN to learn more about the science and evidence of SmartLoop® technology. Jason E. Pope, MD, DABPM, FIPP Patrick Buchanan, M.D. Johnathan Goree Erika Petersen Chau M. Vu, M.D. Patrick McGinn, PA-C To learn more about SmartLoop® technology exclusively from Saluda Medical, visit: https://lnkd.in/gX6abP8Z #KnowtheDose #ControltheDose #BiomarkerbasedDosing Risks and Important Safety Info https://lnkd.in/d2XZ_Asn Rx Only The Saluda Medical Evoke® SCS System is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs.

Recently, we spent an exciting Saturday morning in New Orleans at the Ochsner Pain Symposium. At the symposium, we were joined by an Evoke® System patient, Heather, to share with clinicians a live demonstration of SmartLoop® dose-control technology and the ability to leverage biomarkers to drive objective therapy optimization. Thank you to Dr. yashar Eshraghi and Hazem Eissa at Ochsner Health, and Maged Guirguis, Chairman of Pain Med Services, for sharing your expertise. Thank you to Mena N. Mekhail, D.O. and  Leah Muller, MD PhD for your help creating this experience from science to treatment. To learn more about SmartLoop® technology exclusively from Saluda Medical, visit: https://lnkd.in/gX6abP8Z #KnowtheDose #ControltheDose #BiomarkerbasedDosing Risks and Important Safety Info https://lnkd.in/d2XZ_Asn Rx Only The Saluda Medical Evoke® SCS System is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs.

Nurses from around Europe met in London to learn more about using biomarker-based dosing to objectively optimize therapy leading to a new level of predictability and durability of outcomes. Thank you to our European Nurse partners for your engagement and passion to ensure the best possible outcomes for your SCS patients. Caro Edelbroek @Karen Sanderson Pieter Van Looy Ralph Aarsman Wilma Vissink Colette Schulz Merry Macdonald Jenny Jennings #KnowtheDose #ControltheDose #BiomarkerbasedDosing Learn more about the Evoke® System, visit: https://lnkd.in/gX6abP8Z Risks and Important Safety Info https://lnkd.in/d2XZ_Asn  Rx Only  The Saluda Medical Evoke® SCS System is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs.

Congratulations to Dr. Jason E. Pope, MD, DABPM, FIPP for earning Top 3 abstract at the Pacific Spine and Pain Society (PSPS) 5th Annual Conference last weekend! Dr. Pope detailed how objective, biomarker-based dosing drives maximum pain relief in SCS. Objective, Not Subjective. To read the full publication on using objective neural metrics to drive maximum analgesic effect, visit: https://lnkd.in/ei_jZJ7w To learn more about SmartLoop® technology exclusively from Saluda Medical, visit: https://lnkd.in/gX6abP8Z   #KnowtheDose #ControltheDose #BiomarkerbasedDosing Risks and Important Safety Info https://lnkd.in/d2XZ_Asn Rx Only The Saluda Medical Evoke® SCS System is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs.

The Trial phase of SCS have traditionally relied solely on patient feedback and if the device was on over the trial period to evaluate success or not. SmartLoop® Dose-Control Technology changes that. Last week, Dr. Dustin Reynolds, MD at OrthoNeuro in Ohio completed a trial with a patient who presented with low back and buttock pain. After two days, the patient reported only around 30% pain relief despite using the device continuously. Upon looking at the objective neural metrics, it was observed the neural dose was 1.2, meaning it was 20% above ECAP threshold which is below the published value of 1.4 that has shown to drive max pain relief. The patient’s neural dose was increased to 1.4 based on published data resulting in an increase in pain relief to 80% and the patient becoming a profound responder. Objective, Not Subjective. To read more about how to use neural metrics to drive max analgesic effect, visit our website at: https://lnkd.in/ei_jZJ7w To learn more about SmartLoop® technology exclusively from Saluda Medical, visit: https://lnkd.in/gX6abP8Z    #KnowtheDose #ControltheDose #Biomarkerbaseddosing Individual results may vary Risks and Important Safety Info https://lnkd.in/d2XZ_Asn Rx Only The Saluda Medical Evoke® SCS System is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs.

Recently published data has shown that each patient’s unique ECAP threshold can be used as a biomarker to objectively set the target neural dose to drive maximum pain relief. Last week, Dr. Derron Wilson, MD, FIPP at Goodman Campbell Brain and Spine completed an Evoke® SmartLoop® Trial on a patient who has been experiencing chronic bilateral back and leg pain since L4-L5 surgery in 2011. The patient presented with constant 10/10 pain and their goals for the trial were to walk, stand, sleep, and go camping again with less pain. On Day 0 of the trial, an ECAP and activation plot were captured, enabling an objective dose to be set of 48µV using the novel dose ratio metric of 1.4. The patient reported rapid onset of pain relief and by the end of the trial, the patient reported 100% pain relief and exceeded all of their goals and expectations. At the conclusion of a trial, only Saluda Medical provides a readout of objective neural metrics providing transparency and confidence in the SCS evaluation. To read more about how to use neural metrics to drive max analgesic effect, visit our website at: https://lnkd.in/ei_jZJ7w To learn more about SmartLoop® technology exclusively from Saluda Medical, visit: https://lnkd.in/gX6abP8Z #KnowtheDose #ControltheDose #BiomarkerbasedDosing Individual results may vary Risks and Important Safety Info https://lnkd.in/d2XZ_Asn Rx Only The Saluda Medical Evoke® SCS System is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs.

How important is it to know the dose in SCS and be able to set this objectively for each of your patients? How important is it to control the dose and ensure tight adherence to the prescribed ECAP dose? This is what our esteemed faculty discussed with the attendees at our largest European SENSE Meeting to date last week in Cologne, Germany. For the first time, we can use the ECAP threshold as a biomarker to tailor each patient’s neural dose. By leveraging objective data from outside the clinic, we can optimize patient outcomes. SmartLoop™ Technology continuously adjusts with every pulse, maintaining strict adherence to the prescribed ECAP dose and ensuring consistent relief with every heartbeat, breath, and movement. Thank you to all our faculty and attendees for joining us in Cologne, and for your engagement and passion to ensure the best possible outcomes for your SCS patients. Faculty Prof. Dr. med. Rezvan Ahmadi Christian Wille @ Dr Bjorn Carsten Schultheis Priv.-Doz. Dr. Faycal El Majdoub Johan Van de Minkelis Prof. Dr. Jarek Maciaczyk @ Stefan Schu #KnowtheDose #ControltheDose Learn more about the Evoke® System, visit: https://lnkd.in/gX6abP8Z    Risks and Important Safety Info https://lnkd.in/d2XZ_Asn   Rx Only   The Saluda Medical Evoke® SCS System is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs.